Skip to main content
SpringerLink
Log in

Weight Gain in Women with Breast Cancer Treated with Adjuvant Cyclophosphomide, Methotrexate and 5-Fluorouracil. Analysis of Resting Energy Expenditure and Body Composition

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background. Weight gain is a common side effect observed in women undergoing adjuvant chemotherapy for breast cancer. Among possible causes a direct effect of chemotherapy on metabolism has been proposed. Body composition variations after adjuvant chemotherapy suggest the occurrence of sarcopenic obesity, possibly due to ovarian failure. We investigated acute and chronic effects of adjuvant chemotherapy on body weight, resting energy expenditure (REE) and plasma catecholamines in a group of menopausal women.

Patients and methods. Thirty menopausal women with stage I–II breast cancer were recruited for the study. We measured REE and respiratory quotient (RQ) and body composition at the beginning and after 3 and 6 months of adjuvant cyclophosphomide, methotrexate, and 5-fluorouracil (CMF). REE, RQ, and plasma catecholamines were assessed before and after each chemotherapy session. At each session food intake was also assessed in all patients, by a food diary. Seven patients out of the group of 30 were also evaluated after a placebo infusion (saline).

Results. A significant weight gain was observed in all women (70.5 ± 3 v.s. 67.7 ± 3 kg, p < 0.001), with increase in both fat-free mass (FFM) (45.2 ± 1.5 v.s. 43.6 ± 1.3 kg, p < 0.001) and fat-mass (FM) (25.3 ± 1.7 v.s. 24.1 ± 1.8 kg, p < 0.005). A decrease in REE and RQ was observed both during CMF and placebo infusion (p < 0.05). During acute CMF and placebo infusion a reduction of plasma levels of noradrenaline was observed at the first and last session. REE increased progressively during the study period.

Conclusions. CMF therapy apparently has no effect on REE either acutely or during a 6-month-period; the increased REE observed in the long-term is likely due to the concomitant increase in FFM. The lack of evidence of sarcopenic obesity, at variance with previous literature, is likely due to different patient selection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Knobf MT, Mullen JC, Xistris D, Moritz DA: Weight gain in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 10: 28–34, 1983

    Google Scholar 

  2. Chlebowski RT, Rose D, Buzzard IM, Blackburn GL, Insull W, Grosvenor M, Elashoff R, Wynder EL: Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. Breast Cancer Res Treat 20: 73–84, 1991

    Google Scholar 

  3. Huntington MO: Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 56: 472–474, 1985

    Google Scholar 

  4. Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd NF: Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 5: 195–200, 1985

    Google Scholar 

  5. Foltz AT: Weight gain among stage II breast cancer patient: a study of five factors. Oncol Nurs Forum 12: 21–26, 1985

    Google Scholar 

  6. Hernandez BM, Bonomi P, Hoeltgen T: Weight gain during adjuvant chemotherapy for stage II breast cancer (Abstract). Proc Am Soc Clin Oncol 2: 108, 1983

    Google Scholar 

  7. Knobf MT: Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy. Cancer 66: 1392–1401, 1990

    Google Scholar 

  8. Cheney CL, Mahloch J, Freeny P: Computerized tomography assess-ment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr 66: 141–146, 1996

    Google Scholar 

  9. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH: Weight change in women treated with adjuvant therapy or observed following mastectomy for nodepositive breast cancer. J Clin Oncol 8: 1327–1334, 1990

    Google Scholar 

  10. Goodwin P, Panzarella T, Boyd N: Weight gain in women with localized breast cancer: a descriptive study. Breast Cancer Res Treat 11: 59–66, 1988

    Google Scholar 

  11. Chlebowsky RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman JR: Long term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7: 23–29, 1986

    Google Scholar 

  12. Cruz JM, Muss HB, Brockshmidt JK, Evans GW: Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy. Semin Oncol 17: 63–67, 1990

    Google Scholar 

  13. De Conti RC: Weight gain in the adjuvant chemotherapy of breast cancer. Proc Am Soc Clin Oncol 1: 73, 1982

  14. Dixon J, Moritz D, Baker F: Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum 5: 5–7, 1978

    Google Scholar 

  15. Donegan WL, Hartz AJ, Rimm AA: The association of body weight gain and recurrence cancer of the breast. Cancer 41: 1590–1594, 1978

    Google Scholar 

  16. Freedman L, Clifford C, Messina M: Analysis of dietary fat, calories, body weight and the development of mammary tumors in rats and mice: a review. Cancer Res 50: 5710–5719, 1990

    Google Scholar 

  17. Ingram DM, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D: Obesity and breast disease, the role of the female sex hormones. Cancer 64: 1049–1053, 1989

    Google Scholar 

  18. Plymate SR, Jones LA, Matej LA, Friedl KE: Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin. Steroids 52: 339–340, 1988

    Google Scholar 

  19. Pugeat M, Crave JC, Elmidani M, Nicolas MH, Garoscio-Cholet M, Lejeune N, Dechaud H, Tourniaire J: Pathophysiology of sex hormone binding globulin (SHBG): relationship to insulin. J Steroid Biochem Mol Biol 40: 841–849, 1991

    Google Scholar 

  20. Shah M, Jeffery RV: Is obesity due to overeating and inactivity, or a defective metabolic rate ? A review. Ann Behav Med 13: 73–81, 1991

    Google Scholar 

  21. Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, Trideau M, Hood N, Redwood S: Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17: 120–129, 1999

    Google Scholar 

  22. Demark-Wahnefried W, Hars V, Conaway MR, Havlin K, Rimer BK, McElveen G, Winer EP: Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr 65: 1495–1501, 1997

    Google Scholar 

  23. Denmark-Wahnefried W, Winer EP, Rimer BK: Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11: 1418–1429, 1993

    Google Scholar 

  24. Aslani A, Smith RC, Allen BJ, Levi JA: Changes in body composition during adjuvant chemotherapy for breast cancer. Appl Radiat Isotop 49: 637–638, 1998

    Google Scholar 

  25. Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA: Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat 57: 285–290, 1999

    Google Scholar 

  26. Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, Blackwell K, Rimer B: Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19: 2381–2389, 2001

    Google Scholar 

  27. Kushner RF, Kunigk A, Alspaugh M, Andronis PT, Leitch CA, Schoeller DA: Validation of bioelectrical-impedance analysis as a measurement of change in body composition in obesity. Am J Clin Nutr 52: 219–223, 1990

    Google Scholar 

  28. Mansell PI, Macdonald IA: Reappraisal of the Weir equation for calculation of metabolic rate. Am J Physiol 27: R1347–R1354, 1990

    Google Scholar 

  29. Guo SS, Zeller C, Chumlea WC, Siervogel RM: Aging, body composition and lifestyle: the Fels longitudinal study. Am J Clin Nutr 70: 405–411, 1999

    Google Scholar 

  30. Hoskin PJ, Hashley S, Yarnold JR: Weight gain after primary surgery for breast cancer-effect of tamoxifene. Breast Cancer Res Treat 22: 129–132, 1992

    Google Scholar 

  31. Boyd NF: Nutrition and breast cancer. J Natl Cancer Inst 85: 6–7, 1993

    Google Scholar 

  32. Bonadonna G, Valagussa P, Rossi A: Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5: 95–115, 1985

    Google Scholar 

  33. Saad MF, Alger SA, Zurlo F, Young JB, Bogardus C, Ravussin E: Ethnic differences in sympathetic nervous system mediated energy expenditure. Am J Physiol 261: E789-E794, 1991

  34. Del Rio G, Marrama P, Fiorani P, Della Casa L: Very low calorie diet induces opposite effects on sympathetic nervous system and adrenomedullary responses. Int J Obes 13 (suppl 2): 173–175, 1989

    Google Scholar 

  35. Webber J, Taylor J, Greathead, Dawson J, Buttery PJ, Macdonald IA: A comparison of thermogenic, metabolic and haemodynamic responses to infused adrenaline in lean and obese subjects. Int J Obes 18: 717–724, 1994

    Google Scholar 

  36. Ravussin E, Bogardus C: Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilisation. Am J Clin Nutr 49: 968–975, 1989

    Google Scholar 

  37. Mukhopadhyay MG, Larkin S: Weight gain in cancer patients on chemotherapy (abstract). Proc Am Soc Clin Oncol 5: 254, 1986

  38. Brewin T: Can a tumor cause the same appetite perversion or taste change as pregnancy? Lancet 2: 907–908, 1980

    Google Scholar 

  39. Grindel C, Cahill C, Walker M: Food intake of women with breast cancer during their first six months of chemotherapy. Oncol Nurs Forum 16: 401–407, 1989

    Google Scholar 

  40. Kutynec CL, McCargar L, Barr SI, Hislop TG: Energy balance in women with breast cancer during adjuvant treatment. J Am Diet Assoc 99 (10): 1222–1227, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Modena, Italy

    G. Del Rio, L. Valeriani, R. Menozzi, M. Bondi & M. Bertolini

  2. Department of Oncological Science, University of Modena, Modena, Italy

    S. Zironi, L. Piccinini, M.C. Banzi & M. Federico

Authors
  1. G. Del Rio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Zironi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Valeriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Menozzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Bondi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Bertolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Piccinini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M.C. Banzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Federico
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rio, G.D., Zironi, S., Valeriani, L. et al. Weight Gain in Women with Breast Cancer Treated with Adjuvant Cyclophosphomide, Methotrexate and 5-Fluorouracil. Analysis of Resting Energy Expenditure and Body Composition. Breast Cancer Res Treat 73, 267–273 (2002). https://doi.org/10.1023/A:1015892714162

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015892714162

Search

Navigation